Literature DB >> 7679486

T-cell abnormalities in common variable immunodeficiency.

J S Jaffe1, E Eisenstein, M C Sneller, W Strober.   

Abstract

Common variable immunodeficiency (CVI) is a heterogeneous condition marked by a number of different immunologic defects. One group of patients, perhaps 60% of the CVI group as a whole, is characterized by T cells that produce reduced amounts of IL-2 (mRNA and protein product), IL-4, and IL-5 (mRNA) when stimulated with phytohemagglutinin. This defect does not extend to all lymphokines, however, because the cells produce normal amounts of interferon-gamma (mRNA and protein product) when exogenous IL-2 is present. Recently, we have reexamined the T cell lymphokine production defect using a panoply of T-cell activation stimuli and have shown that the defect is a subtle one that depends on activation of the cell via the CD3-T-cell receptor complex. Because T cells proliferate normally when stimulated via this receptor, this finding suggests the presence of a "downstream" defect, perhaps one involving the factors that are necessary for activation of lymphokine genes. A second form of CVI, in this case involving approximately 30% of the CVI group as a whole, is characterized by a reduced CD4/CD8 ratio and elevated numbers of CD8+ T cells bearing the CD57 marker. Although the CD4+ T cells in this patient group elaborate normal amounts of IL-2 under various activation conditions, their CD8+ T cells produce increased amounts of interferon-gamma. Furthermore, the CD8+ T cells in this case act as "suppressor" T cells, which suppress IgG production but not IgM production of purified (normal) SAC+, IL-2-induced B cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679486     DOI: 10.1203/00006450-199305001-00128

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  14 in total

1.  Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease.

Authors:  Shradha Agarwal; Paul Smereka; Noam Harpaz; Charlotte Cunningham-Rundles; Lloyd Mayer
Journal:  Inflamm Bowel Dis       Date:  2011-01       Impact factor: 5.325

2.  Human cytomegalovirus infection is not increased in common variable immunodeficiency.

Authors:  C G Mullighan; S J Read; A G Bird; J B Kurtz; H M Chapel; K I Welsh
Journal:  J Clin Immunol       Date:  1996-09       Impact factor: 8.317

3.  Serum soluble CD23 in patients with hypogammaglobulinaemia.

Authors:  A S Bansal; M R Haeney; S Cochrane; R S Pumphrey; L M Green; M Bhavnani; P B Wilson
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

4.  Immune-mediated diseases and immunodeficiencies associated with thymic epithelial neoplasms.

Authors:  Muhammad Rizwan Khawaja; Robert P Nelson; Nicholas Miller; Sunil S Badve; Elizabeth Loehrer; Magdalena Czader; Susan M Perkins; Kenneth Kesler; Patrick J Loehrer
Journal:  J Clin Immunol       Date:  2012-01-08       Impact factor: 8.317

5.  Common variable immunodeficiency in horses is characterized by B cell depletion in primary and secondary lymphoid tissues.

Authors:  M Julia B F Flaminio; Rebecca L Tallmadge; Cristina O M Salles-Gomes; Mary Beth Matychak
Journal:  J Clin Immunol       Date:  2008-08-02       Impact factor: 8.317

6.  Impaired up-regulation of CD70 and CD86 in naive (CD27-) B cells from patients with common variable immunodeficiency (CVID).

Authors:  C Groth; R Drager; K Warnatz; G Wolff-Vorbeck; S Schmidt; H Eibel; M Schlesier; H-H Peter
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

Review 7.  Common variable immunodeficiency: etiological and treatment issues.

Authors:  Sean Deane; Carlo Selmi; Stanley M Naguwa; Suzanne S Teuber; M Eric Gershwin
Journal:  Int Arch Allergy Immunol       Date:  2009-07-01       Impact factor: 2.749

8.  Defective integration of activating signals derived from the T cell receptor (TCR) and costimulatory molecules in both CD4+ and CD8+ T lymphocytes of common variable immunodeficiency (CVID) patients.

Authors:  V Thon; H M Wolf; M Sasgary; J Litzman; A Samstag; I Hauber; J Lokaj; M M Eibl
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

Review 9.  The genetics of hypogammaglobulinemia.

Authors:  Bodo Grimbacher; Alejandro A Schäffer; Hans-Hartmut Peter
Journal:  Curr Allergy Asthma Rep       Date:  2004-09       Impact factor: 4.806

Review 10.  Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge.

Authors:  Farnaz Najmi Varzaneh; Bärbel Keller; Susanne Unger; Asghar Aghamohammadi; Klaus Warnatz; Nima Rezaei
Journal:  J Clin Immunol       Date:  2014-05-15       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.